# Handoff: Privileged Physiological Response Admitted for Idea 007 Creation

## Current state

Ideas 001--006 are terminated. There is currently no active Idea.

- **Current Stage**: `PRE_IDEA_PRIVILEGED_RESPONSE_ADMITTED_FOR_IDEA_007`
- **Current active Idea**: none
- **Idea 007**: not created / creation explicitly authorized
- **Paper objective**: first formal method paper, targeting at least a CCF-A Data/Mining/AI venue family
- **Current method family**: `PRIVILEGED_PHYSIOLOGICAL_RESPONSE_SUPERVISION`
- **Strict re-review verdict**: `ACCEPT_TO_CREATE_IDEA_007`
- **Strict re-review score**: `4.17 / 5.00`
- **Reviewer confidence**: medium-high
- **Next CCFA owner**: `ccf-pipeline-orchestrator`
- **Local scientific execution**: not authorized
- **G3/G4 future reserve**: quarantined / uninspected
- **R0 Holdout**: quarantined / uninspected
- **Historical project test split**: untouched / uninspected

## Current packet

`research/memory/model-reset-20260908-privileged-physiological-response/`

Authoritative artifacts:

- `README.md`
- `idea-grounding.md`
- `idea-optimization.md`
- `idea-review.md`
- `closest-work-review.md`

The earlier reusable admission constraint remains useful as a methodological rule but no longer blocks Idea creation:

`research/memory/failures/privileged-response-preidea--response-specificity-not-yet-identified.md`.

## Admission decision

The strict re-review accepts the family for one kill-first Idea/Gate cycle.

The generic learning primitive is not novel. Current prior work separately covers:

- lab-response and monitoring-aware MedRec — REFINE, ChainCare;
- joint medication recommendation and lab-response prediction — MedGCN / Bhoi et al.;
- downstream historical response evidence — DrugDoctor;
- MedRec knowledge distillation — LEADER plus an accepted IJCAI-ECAI 2026 MedRec KD method;
- clinical training-time privileged-modality distillation — OC-Distill;
- clinical future-aware teacher/student transfer — 2026 future-aware blood-glucose forecasting;
- medication-aware physiological-response representations — Wu et al. EMBC 2025;
- generic future-observation teacher to current-only student distillation — Privileged Foresight Distillation 2026.

The search-scoped surviving delta is therefore:

> medication-in-context realized post-administration physiological **values** as positive-event, training-only privileged supervision for a strictly pre-order candidate-medication student, with matched controls proving that the gain depends on focal-medication conditioning, patient-medication-response correspondence, and physiological values rather than generic future prediction, monitoring policy, static medication priors, positive-event weighting, or KD mechanics.

This is scientifically admissible for Idea creation. It is not publication evidence.

## Frozen R1--R3 contract

### R1 — Medication-specificity subtraction

Generic Future-State Auxiliary / Medication-Ablated Future must match recommendation examples, response support, administration anchor, future window, future-value availability, student, latent dimensionality, comparable teacher capacity, auxiliary weight, and update entitlement while removing focal-medication identity and medication-specific construction from the privileged target branch.

If medication ablation is comparable to Proposed:

`STOP_NO_MEDICATION_SPECIFIC_RESPONSE_VALUE`.

### R2 — Monitoring-policy separation

Monitoring-Mask-Only receives the same response support, future window, measurement availability/frequency structure, student, capacity, and update entitlement but no physiological values or value-derived summary.

If Monitoring-Mask-Only is comparable to Proposed:

`STOP_MONITORING_POLICY_SUFFICIENCY`.

### R3 — Equal-support and deployment entitlement

- response supervision applies only to actually administered positive medication events with valid linked future monitoring;
- unchosen medications receive no invented counterfactual response;
- all privileged variants use the same support mask and recommendation examples;
- unsupported examples remain in the recommendation objective;
- student features and normalization are strictly pre-order;
- future/post-order/discharge information is confined to the training-only privileged branch;
- teacher and privileged targets are absent at inference.

Any deployment leakage or unmatched sample/support entitlement invalidates the future Gate.

## Killer controls reserved for Gate 01

After Idea 007 creation, `ccf-experiment-designer` must freeze a Gate 01 that at least covers:

- Strict Pre-Order Base;
- Base + Pre-Order Physiology;
- Generic Future-State Auxiliary / Medication-Ablated Future;
- Static Medication Response Prototype;
- Response Shuffle;
- Monitoring-Mask-Only;
- Proposed privileged-response method;
- Generic KD only if needed to isolate distillation mechanics.

A compatible monitoring-aware MedRec baseline may be included when task alignment permits a fair comparison.

Immediate stop conditions include any simple matched control performing comparably to Proposed, insufficient/materially concentrated response support, student-path leakage, or unequal support/reweighting.

Do not rescue a failed mechanism with a deeper Transformer/Mamba/GNN, larger teacher, wider response window, extra modalities, subgroup mining, or a second response definition under the same Idea.

The experiment designer must turn `materially` / `comparable` into a frozen practical-and-statistical decision rule before training. That is Gate-design work, not another pre-Idea revision.

## Claim boundary

Observed post-administration physiology is an observational response-associated signal under the historical care process. It may reflect severity, co-medications, fluids, procedures, ventilation, dose/route, clinician actions, spontaneous progression, treatment timing, and monitoring policy.

Allowed semantics:

- privileged physiological response supervision;
- medication-in-context physiological trajectory;
- response-associated physiological signature;
- future physiological supervision.

Do not promote it to treatment effect, causal response, medication efficacy, counterfactual outcome, clinical optimality, or individualized causal benefit.

## Latest empirical failure closure

The latest completed empirical reset remains Event-Sourced Regimen Editing M0:

`FAIL_M0_NO_INCREMENTAL_EVENT_EDIT_STRUCTURE`.

`Change` and `D/C` raw workflow actions failed the frozen active-before consistency floors (`0.1723` and `0.1593` versus `0.70`). No model was trained.

This result remains separate from the privileged-response admission decision.

## Routing

Authorized next workflow only:

```text
ccf-pipeline-orchestrator
-> create/admit Idea 007
-> ccf-experiment-designer
-> Gate 01 design-integrity audit
-> push
-> stop before training
```

This handoff does not create Idea 007, authorize response-coverage inspection outside the future Gate preflight, or authorize local training.
